These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20644616)

  • 1. In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds.
    Canavaci AM; Bustamante JM; Padilla AM; Perez Brandan CM; Simpson LJ; Xu D; Boehlke CL; Tarleton RL
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e740. PubMed ID: 20644616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput screening for anti-Trypanosoma cruzi drug discovery.
    Alonso-Padilla J; Rodríguez A
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3259. PubMed ID: 25474364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening.
    Andriani G; Chessler AD; Courtemanche G; Burleigh BA; Rodriguez A
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1298. PubMed ID: 21912715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
    Riley J; Brand S; Voice M; Caballero I; Calvo D; Read KD
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004014. PubMed ID: 26394211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated high-content assay for compounds selectively toxic to Trypanosoma cruzi in a myoblastic cell line.
    Alonso-Padilla J; Cotillo I; Presa JL; Cantizani J; Peña I; Bardera AI; Martín JJ; Rodriguez A
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003493. PubMed ID: 25615687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
    Engel JC; Ang KK; Chen S; Arkin MR; McKerrow JH; Doyle PS
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3326-34. PubMed ID: 20547819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form--DB1965--against Trypanosoma cruzi infection.
    da Silva CF; Batista Dda G; Oliveira GM; de Souza EM; Hammer ER; da Silva PB; Daliry A; Araujo JS; Britto C; Rodrigues AC; Liu Z; Farahat AA; Kumar A; Boykin DW; Soeiro Mde N
    PLoS One; 2012; 7(1):e30356. PubMed ID: 22291940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.
    Ekins S; de Siqueira-Neto JL; McCall LI; Sarker M; Yadav M; Ponder EL; Kallel EA; Kellar D; Chen S; Arkin M; Bunin BA; McKerrow JH; Talcott C
    PLoS Negl Trop Dis; 2015; 9(6):e0003878. PubMed ID: 26114876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of a sensitive, phenotypic, high-throughput image-based assay to identify compound activity against Trypanosoma cruzi amastigotes.
    Sykes ML; Avery VM
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):215-28. PubMed ID: 27120069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
    Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
    Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
    Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
    Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection.
    Henriques C; Henriques-Pons A; Meuser-Batista M; Ribeiro AS; de Souza W
    Parasit Vectors; 2014 Mar; 7():89. PubMed ID: 24589192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes.
    Salas-Sarduy E; Landaburu LU; Karpiak J; Madauss KP; Cazzulo JJ; Agüero F; Alvarez VE
    Sci Rep; 2017 Sep; 7(1):12073. PubMed ID: 28935948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
    Caridha D; Parriot S; Hudson TH; Lang T; Ngundam F; Leed S; Sena J; Harris M; O'Neil M; Sciotti R; Read L; Lecoeur H; Hickman M; Grogl M
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi.
    Díaz MV; Miranda MR; Campos-Estrada C; Reigada C; Maya JD; Pereira CA; López-Muñoz R
    Acta Trop; 2014 Jun; 134():1-9. PubMed ID: 24560964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.